Loading clinical trials...
Loading clinical trials...
Renal Ex Vivo SYN002 Perfusion to Eliminate CMV Transmission: A Safety Trial in Kidney Transplant Recipients
Conditions
Interventions
SYN002
Locations
1
Canada
University Health Network, Toronto General Hospital, Ajmera Transplant Centre
Toronto, Ontario, Canada
Start Date
March 16, 2026
Primary Completion Date
March 16, 2027
Completion Date
December 31, 2027
Last Updated
March 23, 2026
NCT04128189
NCT05702398
NCT06806670
NCT05938712
NCT02555566
NCT05220397
Lead Sponsor
University Health Network, Toronto
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions